-
2024-515092-36-00
5
2022-02-14
Symptomatic Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
-
2023-508242-18-00
6
2021-12-21
Crohn's disease
-
2023-508248-23-00
5
2021-11-26
Non-alcoholic steatohepatitis (NASH)
-
2024-510735-21-00
5
2021-11-26
Atherosclerotic cardiovascular disease (ASCVD)
-
2023-506926-35-00
5
2021-09-24
Atherosclerotic cardiovascular disease, chronic kidney disease and sys
-
2023-506962-30-00
5
2021-03-29
Non-alcoholic steatohepatitis (NASH)
-
2024-514434-20-00
5
2020-06-29
Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)
-
2023-508292-37-00
5
2020-03-06
Cardiovascular Disease
-
2024-512525-83-00
5
2020-01-07
Hypertension
-
2024-510626-89-00
5
2019-11-18
Non-Alcoholic Steatohepatitis (NASH)
-
2023-505478-14-00
5
2019-05-09
Psoriatic Arthritis
-
2024-513125-23-00
4
2025-02-28
Patients with moderate to high risk for cardiac surgery associated- ac
-
2023-508736-62-00
4
2024-08-08
Heart failure (HF) with reduced ejection fraction (HFrEF)
-
2023-505903-22-00
4
2024-07-02
Sepsis associated acute kidney injury
-
2022-502899-23-00
5
2024-04-23
Hepatic Encephalopathy (OHE)
-
2022-501421-20-00
5
2024-04-09
Gout with hyperuricemia
-
2023-506634-70-00
6
2024-02-29
Heart failure with preserved ejection fraction
Secundary mitral valve
-
2023-503315-15-00
4
2023-12-20
Thrombolysis of symptomatic proximal vein thrombosis
-
2023-505859-45-00
4
2023-12-19
Risk for renal damage following open heart surgery
-
2022-501418-69-00
5
2023-11-21
Acute Coronary Syndrome
-
2022-501988-40-00
5
2023-08-17
RSV-associated (subtypes A and B) disease in adults aged 60 years of a
-
2022-500746-16-00
4
2023-08-11
Geographic Atrophy
-
2022-501470-18-00
4
2023-06-26
Thromboembolic disease
-
2022-502375-37-00
6
2023-04-16
heartburn